EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 20 / Numéro 1 (Janvier 2004) Med Sci (Paris), 20 1 (2004) 98-104 Références
Accès gratuit
Numéro
Med Sci (Paris)
Volume 20, Numéro 1, Janvier 2004
Page(s) 98 - 104
Section Dossier technique
DOI https://doi.org/10.1051/medsci/200420198
Publié en ligne 15 janvier 2004
  1. Ruygrok PN, Serruys PW. Intracoronary stenting. From concept to custom. Circulation 1996; 94 : 882–90. [Google Scholar]
  2. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994; 331 : 489–95. [Google Scholar]
  3. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994; 331 : 496–501. [Google Scholar]
  4. Lincoff AM, Califf RM, Moliterno DJ, et al. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of platelet IIb/IIIa inhibition in stenting investigators. N Engl J Med 1999; 341 : 319–27. [Google Scholar]
  5. Eltchaninoff H, Koning R, Tron C, et al. Balloon angioplasty for the treatment of coronary in-stent restenosis : Immediate results and 6-month angiographic recurrent restenosis rate. J Am Coll Cardiol 1998; 32 : 980–4. [Google Scholar]
  6. Hoffmann R, Mintz GS, Dussaillant GR, et al. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation 1996; 94 : 1247–54. [Google Scholar]
  7. Farb A, Sangiorgi G, Carter AJ, et al. Pathology of acute and chronic coronary stenting in humans. Circulation 1999; 99 : 44–52. [Google Scholar]
  8. Rogers C, Edelman ER, Simon DI. A mAb to the beta2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits. Proc Natl Acad Sci USA 1998; 95 : 10134–9. [Google Scholar]
  9. Feldman LJ, Aguirre L, Ziol M, et al. Interleukin-10 inhibits intimal hyperplasia after angioplasty or stent implantation in hypercholesterolemic rabbits. Circulation 2000; 101 : 908–16. [Google Scholar]
  10. Feldman LJ, Mazighi M, Scheuble A, et al. Differential expression of matrix metalloproteinases after stent implantation and balloon angioplasty in the hypercholesterolemic rabbit. Circulation 2001; 103 : 3117–22. [Google Scholar]
  11. The ERASER investigators. Acute platelet inhibition with abciximab does not reduce in-stent restenosis (ERASER study). Circulation 1999; 100 : 799–806. [Google Scholar]
  12. Meurice T, Bauters C, Hermant X, et al. Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS) : A randomised, double-blind, placebo-controlled trial. Lancet 2001; 357 : 1321–4. [Google Scholar]
  13. van der Giessen WJ, Lincoff AM, Schwartz RS, et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 1996; 94 : 1690–7. [Google Scholar]
  14. Tamai H, Igaki K, Kyo E, et al. Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. Circulation 2000; 102 : 399–404. [Google Scholar]
  15. Yamawaki T, Shimokawa H, Kozai T, et al. Intramural delivery of a specific tyrosine kinase inhibitor with biodegradable stent suppresses the restenotic changes of the coronary artery in pigs in vivo. J Am Coll Cardiol 1998; 32 : 780–6. [Google Scholar]
  16. Ye YW, Landau C, Willard JE, et al. Bioresorbable microporous stents deliver recombinant adenovirus gene transfer vectors to the arterial wall. Ann Biomed Eng 1998; 26 : 398–408. [Google Scholar]
  17. Serruys PW, van Hout B, Bonnier H, et al. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet 1998; 352 : 673–81. [Google Scholar]
  18. Gallo R, Padurean A, Jayaraman T, et al. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation 1999; 99 : 2164–70. [Google Scholar]
  19. Suzuki T, Kopia G, Hayashi S, et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 2001; 104 : 1188–93. [Google Scholar]
  20. Sousa JE, Costa MA, Abizaid A, et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries : a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2001; 103 : 192–5. [Google Scholar]
  21. Sousa JE, Costa MA, Abizaid AC, et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents : one-year angiographic and intravascular ultrasound follow-up. Circulation 2001; 104 : 2007–11. [Google Scholar]
  22. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346 : 1773–80. [Google Scholar]
  23. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349 : 1315–23. [Google Scholar]
  24. Jordan MA, Toso RJ, Thrower D, et al. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci USA 1993; 90 : 9552–6. [Google Scholar]
  25. Sollott SJ, Cheng L, Pauly RR, et al. Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat. J Clin Invest 1995, 95 : 1869–76. [Google Scholar]
  26. Heldman AW, Cheng L, Jenkins GM, et al. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis. Circulation 2001; 103 : 2289–95. [Google Scholar]
  27. Farb A, Heller PF, Shroff S, et al. Pathological analysis of local delivery of paclitaxel via a polymer-coated stent. Circulation 2001; 104 : 473–9. [Google Scholar]
  28. Drachman DE, Edelman ER, Seifert P, et al. Neointimal thickening after stent delivery of paclitaxel. Change in composition and arrest of growth over six months. J Am Coll Cardiol 2000; 36 : 2325–32. [Google Scholar]
  29. Colombo A, Drzewiecki J, Banning A, et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003; 108 : 788–94. [Google Scholar]
  30. Klugherz BD, Jones PL, Cui X, et al. Gene delivery from a DNA controlled-release stent in porcine coronary arteries. Nat Biotechnol 2000; 18 : 1181–4. [Google Scholar]
  31. Goueffic Y, Meddahi A, Mezzina M, Mazighi M, Feldman L. Smooth muscle cell seeding after arterial injury. Eur Heart J 2001; 22 : 429. [Google Scholar]
  32. Dzau VJ, Braun-Dullaeus RC, Sedding DG. Vascular proliferation and atherosclerosis : new perspectives and therapeutic strategies. Nat Med 2002; 8 : 1249–56. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.